Host-tumor antagonism. XV. The apparently beneficial effects of acute concurrent infections or of toxin therapy on the course of malignant melanoma.

Host-tumor antagonism. XV. The apparently beneficial effects of acute concurrent infections or of toxin therapy on the course of malignant melanoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Host-tumor antagonism. XV. The apparently beneficial effects of acute concurrent infections or of toxin therapy on the course of malignant melanoma. Abstract Text:

Host-tumor antagonism. XV. The apparently beneficial effects of acute concurrent infections or of toxin therapy on the course of malignant melanoma. Publishing Authors By Initials

For similar biological factors: toxins, biological research abstracts see: biological factors: toxins, biological research

PUBMED ID PMID:

MEDLINE DATE:

Host-tumor antagonism. XV. The apparently beneficial effects of acute concurrent infections or of toxin therapy on the course of malignant melanoma. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of the American Geriatrics Society

VOLUME: 8

Page Numbers: 378-97

Journal Abbreviation: J Am Geriatr Soc

ISSN: 0002-8614

DAY: 10

MONTH: May

YEAR: 1960

Host-tumor antagonism. XV. The apparently beneficial effects of acute concurrent infections or of toxin therapy on the course of malignant melanoma. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7503062

Host-tumor antagonism. XV. The apparently beneficial effects of acute concurrent infections or of toxin therapy on the course of malignant melanoma. Keywords Mesh Terms:

KEYWORDS: Toxins, Biological

MESH TERMS: immunology

Chemical & Substance for Abstract: Host-tumor antagonism. XV. The apparently beneficial effects of acute concurrent infections or of toxin therapy on the course of malignant melanoma. Information

Substance Name: Toxins, Biological

Registry Number: 0

Grant and Affiliation Information for Host-tumor antagonism. XV. The apparently beneficial effects of acute concurrent infections or of toxin therapy on the course of malignant melanoma.

AFFILIATION:

Country: Not Available

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Am Geriatr Soc

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Host-tumor antagonism XV The apparently beneficial effects of acute concurrent infections or of toxin therapy on the course of malignant melanoma Related Publications

• Burning sensation of the tongue, (glossodynia); an analysis of cases that are not due to vitamin B deficiency.
• HOST-TUMOR ANTAGONISM. 32. THE EPIDEMIOLOGY OF CANCER.
• HOST-TUMOR ANTAGONISM. 33. CANCER IMMUNITY--A REVIEW AND AN ANALYSIS OF SOME FACTORS IN HOST RESISTANCE TO CANCER.
• Host-tumor antagonism. I. Evidence for the existence of tumor immunity.
• Host-tumor antagonism. II. Hormone dependency of certain cancers.
• Host-tumor antagonism. III. Prolonged survival of certain patients with cancer; fortuitous occurrence or immunity mechanism?
• Host-tumor antagonism. IV. Immunologic possibilities inherent in some of the theories on the nature of cancer.
• Host-tumor antagonism. V. The effect of ionizing radiations (radium and x-ray) upon tumor and host.
• Host-tumor antagonism. 23. The hereditary aspects of cancer.
• Host-tumor antagonism. 27. Nutrition and cancer.
• Host-tumor antagonism. 28. Thoughts on the constitution of a cancer vaccine.
• Host-tumor antagonism. X. Radiation; a double-edged sword.
• Host-tumor antagonism. XI. Recapitulation of various aspects: practical applications of this knowledge to the care of patients.
• Host-tumor antagonism. XIX. Cancer and dysfunction of the liver.
• Host-tumor antagonism. XV. The apparently beneficial effects of acute concurrent infections or of toxin therapy on the course of malignant melanoma.
• Host-tumor antagonism. XVI. The effect of one disease upon another.
• Host-tumor antagonism. XVII. Trauma and cancer.
• Host-tumor antagonism. XX. The influence of pregnancy on tumor growth.
• Host-tumor antagonism. XXI. Rationale of the use of gestational products (including placental extracts) in the therapy of cancer.
• Host-tumor antagonism. XXII. The skin as an immunologic organ.
• Host-tumor antagonism. XXIV. The latent period in the formation of cancer: the "cancer-age" myth.
• Host-tumor antagonism. XXV. The carcinogens in our midst.
• Host-tumor antagonism. XXVI. The controversy on smoking and lung cancer: application of Occam's razor and Loeb's law.
• Host-tumor antagonism. XXXV. Some important aspects of cancer.
• Host-tumor antagonism. XXXVI. Auto-immune disease and cancer: a correlation of data on the lymphocyte, thymus, homograft rejection and somatic mutation.
• Restoration of diuretic response with triamcinolone in refractory cardiac edema.
• The action of neostigmine in supraventricular tachycardias.
• The conservative therapy of endometriosis of the colon with the use of testosterone; report of a case.
• The inactivation of estrogens by lipotropic substances; studies of liver dysfunction.
• The relationship of upper respiratory infections to congestive heart-failure in patients with heart disease.